Burst mitofusin activation reverses neuromuscular dysfunction in murine CMT2A.
Franco A, Dang X, Walton EK, Ho JN, Zablocka B, Ly C, Miller TM, Baloh RH, Shy ME, Yoo AS, Dorn GW 2nd.
Franco A, et al.
Elife. 2020 Oct 19;9:e61119. doi: 10.7554/eLife.61119.
Elife. 2020.
PMID: 33074106
Free PMC article.
The researchers tested a new class of drug called a mitofusin activator on nerve cells grown in the laboratory after being taken from people suffering from CMT2A, and also from a mouse model of the disease. Mitofusin activators improved the structure, fitness …
The researchers tested a new class of drug called a mitofusin activator on nerve cells grown in the laboratory after being tak …